Tailoring Recombinant Protein Quality by Rational Media Design

被引:61
作者
Bruehlmann, David [1 ,2 ]
Jordan, Martin [1 ]
Hemberger, Juergen [3 ]
Sauer, Markus [2 ]
Stettler, Matthieu [1 ]
Broly, Herve [1 ]
机构
[1] Merck Serono SA, Corsier Sur Vevey, Biotech Proc Sci, CH-1809 Fenil Sur Corsier, Switzerland
[2] Univ Wurzburg, Biozentrum, Dept Biotechnol & Biophys, DE-97074 Wurzburg, Germany
[3] Univ Appl Sci Giessen, Inst Biochem Engn & Analyt, DE-35390 Giessen, Germany
关键词
cell culture medium; media design; quality attributes; therapeutic protein; mammalian; glycosylation; HAMSTER OVARY CELLS; ANTIBODY N-GLYCOSYLATION; CHEMICALLY-DEFINED MEDIA; METABOLIC FLUX ANALYSIS; ALPHA-MANNOSIDASE II; FED-BATCH CULTURES; FC-FUSION PROTEIN; MONOCLONAL-ANTIBODY; CHO-CELLS; MAMMALIAN-CELLS;
D O I
10.1002/btpr.2089
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Clinical efficacy and safety of recombinant proteins are closely associated with their structural characteristics. The major quality attributes comprise glycosylation, charge variants (oxidation, deamidation, and C- & N-terminal modifications), aggregates, lowmolecular- weight species (LMW), and misincorporation of amino acids in the protein backbone. Cell culture media design has a great potential to modulate these quality attributes due to the vital role of medium in mammalian cell culture. The purpose of this review is to provide an overview of the way both classical cell culture medium components and novel supplements affect the quality attributes of recombinant therapeutic proteins expressed in mammalian hosts, allowing rational and high-throughput optimization of mammalian cell culture media. A selection of specific and/or potent inhibitors and activators of oligosaccharide processing as well as components affecting multiple quality attributes are presented. Extensive research efforts in this field show the feasibility of quality engineering through media design, allowing to significantly modulate the protein function. (C) 2015 American Institute of Chemical Engineers
引用
收藏
页码:615 / 629
页数:15
相关论文
共 167 条
[1]   Towards dynamic metabolic flux analysis in CHO cell cultures [J].
Ahn, Woo Suk ;
Antoniewicz, Maciek R. .
BIOTECHNOLOGY JOURNAL, 2012, 7 (01) :61-74
[2]   MANNOSTATIN-A AND MANNOSTATIN-B - NEW INHIBITORS OF ALPHA-D-MANNOSIDASE, PRODUCED BY STREPTOVERTICILLIUM-VERTICILLUS VAR QUINTUM ME3-AG3 - TAXONOMY, PRODUCTION, ISOLATION, PHYSICOCHEMICAL PROPERTIES AND BIOLOGICAL-ACTIVITIES [J].
AOYAGI, T ;
YAMAMOTO, T ;
KOJIRI, K ;
MORISHIMA, H ;
NAGAI, M ;
HAMADA, M ;
TAKEUCHI, T ;
UMEZAWA, H .
JOURNAL OF ANTIBIOTICS, 1989, 42 (06) :883-889
[3]   On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database [J].
Apweiler, R ;
Hermjakob, H ;
Sharon, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :4-8
[4]   The impact of glycosylation on the biological function and structure of human immunoglobulins [J].
Arnold, James N. ;
Wormald, Mark R. ;
Sim, Robert B. ;
Rudd, Pauline M. ;
Dwek, Raymond A. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :21-50
[5]   Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application [J].
Asano, N ;
Nash, RJ ;
Molyneux, RJ ;
Fleet, GWJ .
TETRAHEDRON-ASYMMETRY, 2000, 11 (08) :1645-1680
[6]   Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells [J].
Baker, KN ;
Rendall, MH ;
Hills, AE ;
Hoare, M ;
Freedman, RB ;
James, DC .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 73 (03) :188-202
[7]   Marketing approval of mogamulizumab A triumph for glyco-engineering [J].
Beck, Alain ;
Reichert, Janice M. .
MABS, 2012, 4 (04) :419-425
[8]   Oxidation of protein tyrosine or methionine residues: From the amino acid to the peptide [J].
Berges, J. ;
Trouillas, P. ;
Houee-Levin, C. .
COST CHEMISTRY CM0603-MELUSYN JOINT MEETING: DAMAGES INDUCED IN BIOMOLECULES BY LOW AND HIGH ENERGY RADIATIONS, 2011, 261
[9]   Free Light Chain Content in Culture Media Reflects Recombinant Monoclonal Antibody Productivity and Quality [J].
Bhoskar, Prachi ;
Belongia, Brett ;
Smith, Robert ;
Yoon, Seongkyu ;
Carter, Tyler ;
Xu, Jin .
BIOTECHNOLOGY PROGRESS, 2013, 29 (05) :1131-1139
[10]   Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells [J].
Bork, Kaya ;
Reutter, Werner ;
Weldermann, Wenke ;
Horstkorte, Rudiger .
FEBS LETTERS, 2007, 581 (22) :4195-4198